EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallbericht

Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review

L Gleason, E Hunter, A Cohen, J Suriano, N Nikbakht

Dermatology Online Journal · 2023

DOI: 10.5070/d329160215 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatology Online Journal, 2023. Verfasst von L Gleason und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. neda.nikbakht@jefferson.edu. Hauptthemen laut MEDLINE: Psoriasis, Drug Eruptions, Exanthema. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune-related cutaneous adverse events (ircAE) are commonly seen with immune checkpoint inhibitors such as atezolizumab. Atezolizumab-induced psoriasis has been previously reported as an ircAE, especially in patients with pre-existing psoriasis. The severity of the reaction influences treatment of the cutaneous eruption. Biologics should be considered as a treatment option for severe refractory psoriasiform eruptions even in patients with complex medical conditions like chronic infections and malignancy. This is the first reported case of successful treatment of atezolizumab-induced psoriasiform eruption with ixekizumab, a neutralizing IL17A monoclonal antibody, to the best of our knowledge. Herein, we present a 63-year-old man with a history of human immunodeficiency virus and psoriasis who presented with atezolizumab-induced psoriasiform eruption while being treated for metastatic hepatocellular carcinoma. After initiating ixekizumab, atezolizumab was restarted without cutaneous eruption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisDrug EruptionsExanthemaMaleHumansMiddle AgedAntibodies, Monoclonal, Humanized

Substanzen

ixekizumabatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. neda.nikbakht@jefferson.edu.

Zitieren

APA

Gleason, L., Hunter, E., Cohen, A., Suriano, J., & Nikbakht, N. (2023). Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatology Online Journal. https://doi.org/10.5070/d329160215

Vancouver

Gleason L, Hunter E, Cohen A, Suriano J, Nikbakht N. Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatology Online Journal. 2023. doi:10.5070/d329160215

BibTeX
@article{Gleason2023,
  author = {Gleason, L and Hunter, E and Cohen, A and Suriano, J and Nikbakht, N},
  title = {Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review},
  journal = {Dermatology Online Journal},
  year = {2023},
  doi = {10.5070/d329160215}
}
Kostenlos starten →